What is the use of Cholestyramine (Questran)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Cholestyramine should be started at a low dose of 2 to 4 g/d and titrated based on response, with a maximum dose of 24 g/d, to minimize side effects and maximize symptom relief in patients with bile acid diarrhea. This approach is supported by the Canadian Association of Gastroenterology clinical practice guideline on the management of bile acid diarrhea, which suggests gradual dose titration of cholestyramine to clinical response 1. The guideline also recommends starting with a low dose and titrating up to minimize side effects, which is particularly relevant for bile acid sequestrants like cholestyramine due to their high frequency of side effects and intolerance.

Some key points to consider when prescribing cholestyramine include:

  • Starting with a low dose and gradually increasing as tolerated to minimize side effects
  • Taking the medication before meals and other medications to avoid interference with absorption
  • Adequate fluid intake and dietary fiber to help manage constipation
  • Potential depletion of fat-soluble vitamins (A, D, E, K) with long-term use, which may require supplementation
  • The medication works by interrupting the enterohepatic circulation of bile acids, which forces the liver to convert more cholesterol into bile acids, thereby reducing blood cholesterol levels.

It is also important to note that the certainty of evidence for the use of cholestyramine in bile acid diarrhea is generally rated as very low, and therefore, the recommendations are conditional 1. However, the available evidence suggests that cholestyramine is a effective treatment option for patients with bile acid diarrhea, and gradual dose titration can help minimize side effects and maximize symptom relief.

From the FDA Drug Label

Cholestyramine for Oral Suspension, USP powder is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet Therapy with lipid-altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. The main use of cholestyramine is as an adjunct to diet for reducing elevated serum cholesterol in patients with primary hypercholesterolemia who do not respond to diet alone 2.

  • Key points:
    • Indication: reduction of elevated serum cholesterol in patients with primary hypercholesterolemia
    • Use: as an adjunct to diet
    • Patient population: those who do not respond adequately to diet alone
    • Goal of treatment: to lower LDL-C levels
    • Monitoring: periodic determination of serum cholesterol and triglyceride levels to confirm initial and adequate long-term response.

From the Research

Cholesteramine Overview

  • Cholesteramine is a medication used to lower cholesterol levels in the blood 3.
  • It is a type of bile acid sequestrant, which works by binding to bile acids in the gut and removing them from the body, thereby reducing the amount of cholesterol produced in the liver 3.

Efficacy and Safety

  • Studies have shown that cholesteramine can be effective in lowering LDL cholesterol levels, particularly when used in combination with other medications such as statins [(3,4)].
  • However, cholesteramine may not be as effective as other medications, such as atorvastatin, in reducing LDL cholesterol levels 3.
  • The safety of cholesteramine has been evaluated in several studies, and it has been found to be generally well-tolerated, with few adverse events reported [(3,4)].

Comparison to Other Treatments

  • Cholesteramine has been compared to other treatments, such as statins and ezetimibe, in several studies [(3,5,4)].
  • These studies have shown that cholesteramine can be an effective alternative to other treatments, particularly for patients who are intolerant to statins or have contraindications to their use 5.
  • However, the choice of treatment will depend on individual patient factors, such as the severity of their hypercholesterolemia and their medical history [(6,7)].

Clinical Considerations

  • Cholesteramine may be considered as an adjunct to diet and lifestyle modifications for patients with primary hypercholesterolemia 3.
  • The medication should be used under the guidance of a healthcare professional, who can monitor the patient's response to treatment and adjust the dosage as needed [(6,7)].
  • Patients should be informed about the potential benefits and risks of cholesteramine, as well as the importance of adhering to their treatment regimen 7.

Related Questions

What should a patient be directly told about their blood work results, specifically regarding their Mean Corpuscular Volume (MCV) of 98.6, Mean Corpuscular Hemoglobin (MCH) of 34.3, elevated Vitamin B12 level of 1046, hypercholesterolemia with a cholesterol level of 217, and high-density lipoprotein (HDL) level of 101?
Should a 77-year-old patient with elevated LDL on lovastatin 40mg increase the dose or switch to a different statin, given no ASCVD?
Does a diabetic patient with elevated Low-Density Lipoprotein (LDL) cholesterol require cholesterol-lowering medication?
Is there an association between statins (3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors) and cancer risk?
What is the next step in managing elevated Low-Density Lipoprotein (LDL) cholesterol levels in a 37-year-old female patient with hyperlipidemia?
What is the treatment for Group C Streptococcus (GCS) infection on throat culture?
What is the diagnosis for a patient with a right adnexal (adnexa of the uterus) septated, cystic lesion measuring up to 5.4 centimeters, presenting with right flank pain?
What is the likelihood of developing muscle cramping with HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase inhibitors, commonly referred to as statins?
What is the diagnosis and treatment for tibiotalar (ankle) joint effusion?
What is the diagnosis and treatment for Cholangitis (inflammation of the bile duct)?
What is the recurrence rate of pleomorphic adenomas (benign salivary gland tumors) after surgical resection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.